Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Wynnvision LLC
Profile last edited on: 8/21/19      CAGE: 7Q9M7      UEI: UHSSK72NUR11

Business Identifier: Combating VAP: ventilator-associated pneumonia
Year Founded
2016
First Award
2018
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

5609 Promontory Pointe Road
Midlothian, VA 23112
   N/A
   N/A
   www.wynnvision.com
Location: Single
Congr. District: 07
County: Chesterfield

Public Profile

Wynnvision is organized around development of a new approach to reducing significantly the incidence of ventilator-associated pneumonia (VAP) and ventilator-related infections. The firm's approach explicitly does not make use of antibiotics or antimicrobials that lead to “super-bugs.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$225,000
Phase II Dollars
$1,495,137
Total Awarded
$1,720,137

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 2 NIH $1,720,137
Project Title: Antimicrobial and Biocompatible Endotracheal Tubes

Key People / Management

  Xuejun (Kenneth) Wen -- President

  Olga Zolotarskay

Company News

There are no news available.